- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 17/02 - Peptides immobilisés sur, ou dans, un support organique
Détention brevets de la classe C07K 17/02
Brevets de cette classe: 377
Historique des publications depuis 10 ans
|
22
|
19
|
28
|
26
|
21
|
25
|
28
|
19
|
12
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 19784 |
9 |
| Ith Immune Therapy Holdings | 16 |
9 |
| Merck Millipore Ltd. | 35 |
6 |
| Lawrence Livermore National Security, LLC | 1918 |
5 |
| Finncure Oy | 10 |
5 |
| Immunwork Inc. | 25 |
4 |
| L.e.a.f. Holdings Group LLC | 106 |
4 |
| Leukocare AG | 40 |
4 |
| MedImmune Limited | 607 |
4 |
| Centre National de La Recherche Scientifique | 10284 |
3 |
| FUJIFILM Corporation | 29188 |
3 |
| Board of Regents, The University of Texas System | 5738 |
3 |
| Kaneka Corporation | 4488 |
3 |
| The Trustees of the University of Pennsylvania | 4295 |
3 |
| Animal Allergy Clinical Laboratories Inc. | 15 |
3 |
| The Brigham and Women's Hospital, Inc. | 2164 |
3 |
| The Council of the Queensland Institute of Medical Research | 156 |
3 |
| Denka Company Limited | 2525 |
3 |
| National University Corporation Kyoto Institute of Technology | 194 |
3 |
| Nippon Zenyaku Kogyo Co., Ltd. | 65 |
3 |
| Autres propriétaires | 294 |